Trial Profile
Pregabalin in aneurysmal subarachnoid haemorrhage
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 May 2018
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Subarachnoid haemorrhage
- Focus Therapeutic Use
- 30 Apr 2018 Status changed from not yet recruiting to completed.
- 15 Nov 2016 New trial record